Democrat senators are begging Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. to keep a proposed Biden-era rule pertaining to obesity drugs. In November, the […] ...

As Stat reports, though, much of President Donald Trump's executive order would need further rulemaking or other actions to have any effect. Other Medicare news is on anti-obesity drugs, Humana, Cone ...

A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

President Donald Trump and Health Secretary Robert F. Kennedy Jr. have pledged to “make America healthy again.” If Congress ...

A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity medications.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

As President Trump wages war on wasteful spending and DEI, a $16 billion-a-year health equity program is flying under the ...

The Centers for Medicare & Medicaid Services on Friday issued a revised, slimmer Medicare Advantage technical rule for 2026 that does not include new guardrails on plans’ use of artificial ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...

32,729 people played the daily Crossword recently. Can you solve it faster than others?32,729 people played the daily ...

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...